Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AbbVie
Company Monitoring Page for AbbVie
latest headlines for company on cafepharma
Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
Yahoo/Reuters
Fri, 07/14/17 - 07:58 am
Tags:
Novartis
,
rheumatoid arthritis
,
generics
,
Sandoz
,
Amgen
,
Enbrel
,
JNJ
,
Remicade
,
AbbVie
,
Humira
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now
Motley Fool
Mon, 07/10/17 - 11:34 pm
Tags:
Celgene
,
Revlimid
,
Bristol-Myers Squibb
,
Opdivo
,
Merck
,
Keytruda
,
AbbVie
,
JNJ
,
Imbruvica
,
Pfizer
,
Ibrance
,
cancer
Key Humira patent gets struck down for the second time in as many months
Fierce Pharma
Sun, 07/9/17 - 11:38 am
Tags:
Humira
,
patents
,
AbbVie
,
Boehringer Ingelheim
,
Coherus Biosciences
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
Tags:
prescription data
,
Sanofi
,
Lantus
,
Roche
,
Herceptin
,
Avastin
,
Celgene
,
Revlimid
,
JNJ
,
Merck
,
Remicade
,
Biogen
,
Rituxan
,
Amgen
,
Enbrel
,
Gilead Sciences
,
Harvoni
,
AbbVie
,
Humira
[video]Will AbbVie Outsmart Biosimilars, and Can Clovis Win the PARP Race?
Motley Fool
Tue, 06/27/17 - 09:45 am
Tags:
AbbVie
,
biosimilars
,
Humira
,
Clovis Oncology
,
Rubraca
,
Novartis
,
Regeneron
,
Eylea
EMA Recommends New HCV, Cancer and MS Drugs for Approval
RAPS.org
Sat, 06/24/17 - 09:11 am
Tags:
Europe
,
EMA
,
hepatitis C
,
multiple sclerosis
,
breast cancer
,
renal cell carcinoma
,
AbbVie
,
Maviret
,
Gilead Sciences
,
Vosevi
,
Biogen
,
Amgen
,
Samsung Bioepis
,
biosimilars
,
Humira
,
Novartis
,
Kisqali
,
EUSA
,
Fotivda
AbbVie's Eagerly Anticipated Followup to Humira Is Coming: What You Need to Know
Motley Fool
Fri, 06/23/17 - 03:37 pm
Tags:
AbbVie
,
Humira
,
Upadacitinib
,
JAK inhibitors
,
autoimmune disease
AbbVie Stock Just Hit a 52-Week High: Here's Why It Should Go Even Higher
Motley Fool
Mon, 06/19/17 - 12:01 am
Tags:
AbbVie
,
Humira
First PhIII trial of AbbVie’s upadacitinib a success
Pharma Times
Sun, 06/11/17 - 05:34 pm
Tags:
AbbVie
,
Upadacitinib
,
clinical trials
,
rheumatoid arthritis
Abbvie Vaults First Pivotal Hurdle With Oral RA Candidate
Seeking Alpha
Fri, 06/9/17 - 11:20 am
Tags:
AbbVie
,
rheumatoid arthritis
,
Upadacitinib
AbbVie, Novo Nordisk and Takeda Have the Best Reputations Among Pharma Companies According to Reputation Institute Global Pharma Reptrak® Study
PR Web
Thu, 06/1/17 - 09:19 am
Tags:
reputation
,
AbbVie
,
Novo Nordisk
,
Takeda
Top Presentations to Look for at ASCO
Yahoo/24-7 Wall St
Tue, 05/30/17 - 11:35 am
Tags:
ASCO 2017
,
Merck
,
AbbVie
,
Eli Lilly
,
Bluebird Bio
,
Epizyme
,
Juno Therapeutics
,
Kite
,
Merus
AbbVie preps an FDA pitch of promising PhIII data for blockbuster hopeful elagolix
Endpoints
Sat, 05/20/17 - 01:13 pm
Tags:
AbbVie
,
Elagolix
,
clinical trials
,
endometriosis
Key Humira patent goes down via IPR—but biosims makers shouldn't celebrate yet, analysts warn
Fierce Pharma
Thu, 05/18/17 - 12:09 am
Tags:
Humira
,
patents
,
AbbVie
,
biosimilars
AbbVie's JAK-1 inhibitor hits the mark in Crohn's disease
BioPharma Dive
Thu, 05/11/17 - 11:17 am
Tags:
AbbVie
,
JAK inhibitors
,
Crohn's Disease
,
Upadacitinib
Gilead Vs. AbbVie: A DGI Thunderdome Match
Seeking Alpha
Mon, 05/8/17 - 09:55 pm
Tags:
Gilead Sciences
,
AbbVie
AbbVie Is Focused on Label Expansion of Imbruvica in 2017
Market Realist
Tue, 05/2/17 - 11:22 am
Tags:
AbbVie
,
Imbruvica
,
non-Hodgkin's lymphoma
,
mantle cell lymphoma
,
graft vs host disease
AbbVie Reports Humira Sales Growth in 1st Quarter
Yahoo/GuruFocus
Sun, 04/30/17 - 12:49 pm
Tags:
AbbVie
,
Humira
,
earnings
These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016
Motley Fool
Sat, 04/29/17 - 10:12 am
Tags:
earnings
,
drug pricing
,
Biogen
,
Eli Lilly
,
AbbVie
,
Allergan
,
Merck
,
Pfizer
,
Amgen
AbbVie stock surges 1.5% after first-quarter profit, revenue beats
Marketwatch
Thu, 04/27/17 - 09:42 am
Tags:
AbbVie
,
earnings
Pages
« first
‹ previous
…
45
46
47
48
49
50
51
52
53
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.